Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Borrow rate
1.26%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | −$2.5M | $1.7M | $2.5M | $2.4M | $3.4M | $4.3M | $1.5M | $785.0K |
| Cost of revenue | $2.5M | $47.0K | $46.0K | $10.2M | $12.0M | $169.0K | $179.0K | $29.8M |
| Gross profit | −$5.0M | $1.6M | $2.5M | −$7.7M | −$8.6M | $4.1M | $1.3M | −$29.0M |
| Gross margin | 200.0% | 97.2% | 98.2% | -318.9% | -255.6% | 96.1% | 88.0% | -3690.2% |
| R&D | $17.2M | $21.5M | $29.7M | $10.2M | $12.5M | $24.1M | $33.0M | $29.8M |
| Operating income | −$25.9M | −$30.7M | −$39.1M | −$33.1M | −$17.5M | −$31.4M | −$44.9M | −$41.7M |
| EBITDA | −$17.7M | −$30.4M | $1.0M | −$33.1M | −$17.4M | −$31.2M | −$44.9M | $2.2M |
| Net income | −$17.7M | −$30.4M | −$38.4M | −$15.9M | −$17.2M | −$31.3M | −$43.4M | −$39.5M |
| Net margin | 705.9% | -1818.3% | -1523.9% | -656.2% | -509.9% | -725.4% | -2912.3% | -5029.2% |
| EPS (diluted) | -8.52 | -12.22 | -11.52 | -30.81 | -0.69 | -1.94 | -16.50 | -13.43 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1M | $-6.16 | $-6.16–$-6.16 | 1 |
| 2027 | $1M | $-6.79 | $-6.79–$-6.79 | 1 |
| 2028 | $1M | $-4.77 | $-4.77–$-4.77 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ONCT.
No tracked institution reports a position in ONCT as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-01-08 | 1-for-20reverse |
| 2016-12-06 | 1-for-10reverse |
No one on the platform has traded ONCT yet.
| $1M |
| — |
| NBSENeuBase Therapeutics, Inc. | $0.38 | -1.56% | $1M | — |
| NMTRQ9 Meters Biopharma, Inc. | $0.00 | +0.00% | $145 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.3× sales vs its 44.1× historical median P/S.
Fair value ≈ $10.26 · price $0.53 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
@GoPatzGo123 @FoxM07 $ONCT Yah listen to your buddy Fuzzyballs. LOL !
View on StockTwits ↗$ONCT https://m.aktiencheck.de/analysen/Artikel-Oncternal_Therapeutics_Nears_Final_Liquidation_Phase-19506697
View on StockTwits ↗$ONCT I have read it, lets Hope some money back in july 2026
View on StockTwits ↗$ONCT https://www.oncternal.com/assets/letter-to-shareholders-12-23-25.pdf
View on StockTwits ↗$ONCT $RATSFARTS Small profift....you are a joke and a liar.
View on StockTwits ↗$OPK $ONCT $RATSFARTS Bro you and your ho do not own a single share of either of these stocks. You are a no body here.
View on StockTwits ↗$ONCT $OPK @Ratsfarts Bro you are such a liar. You do not own a single share of ONCT or OPK. You are a total fraud. Buyers beware of this fool. And Rastfarts take your total portfolio of $500 and put it in a a CD because you clearly do not know how to invest in stocks.
View on StockTwits ↗It's Sunday morning ⛅️ and I've been reflective ☺️☕️ I hope you all won't mind this cross post between $BCRX $GRTS $ONCT $ORGN and $TRVN which I've tied together in the attached comparative Nasdaq chart. My notes appear towards the right-hand edge of the image. There is also a request from me related to ANVS in red 🟥 I hope that is useful for you and someone you know. I'm short on time, but please revisit this post later for additional information related to my request. Take care and have a very nice, Sunday 🌻 #CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #NIH #NIA #SEC
View on StockTwits ↗@BiotechValues @skyrockets_Inc Everything this year has been a fail call. $BCAB, $PEPG $JSPR $ONCT, etc etc
View on StockTwits ↗$BCTX $CLRB $NBSE $ONCT this guy @ZhaoSonsWealth was pumping the fuck out of TGL. Now GLMD? 😆 🤣 😂
View on StockTwits ↗@BiotechValues I'm not denying they are saying that...but it's something that a lot of them say, def not a guarentee. $ONCT was the same way
View on StockTwits ↗$ONCT when we Will get paid? How much? Still no details or CVR in my account.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.